Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-L-tyrosine PET.
Elena K BauerGabriele StoffelsTobias BlauGuido ReifenbergerJörg FelsbergJan M WernerPhilipp LohmannJurij RosenGarry CecconCaroline TscherpelMarion RappMichael SabelChristian P FilssNadim J ShahBernd NeumaierGereon R FinkKarl-Josef LangenNorbert GalldiksPublished in: European journal of nuclear medicine and molecular imaging (2020)
Our data suggest that dynamic FET PET allows the identification of patients with longer OS among patients with newly diagnosed IDH-wildtype GBM and AA.